ArticleJournal of pain research2016

A double-blind, randomized, placebo-controlled pilot trial to determine the efficacy and safety of ibudilast, a potential glial attenuator, in chronic migraine.

Yuen H Kwok et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.